Cargando…
Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: the SAFE study
BACKGROUND: In haemodialysis, maintaining patency of the extracorporeal circuit requires the use of anticoagulants. Although (low molecular weight) heparins are the mainstay, these are not well tolerated in all patients. Alternative approaches include saline infusion, citrate-containing dialysate, r...
Autores principales: | Vandenbosch, Ines, Dejongh, Sander, Claes, Kathleen, Bammens, Bert, De Vusser, Katrien, Van Craenenbroeck, Amaryllis, Kuypers, Dirk, Evenepoel, Pieter, Meijers, Björn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323132/ https://www.ncbi.nlm.nih.gov/pubmed/34345413 http://dx.doi.org/10.1093/ckj/sfaa228 |
Ejemplares similares
-
Discrepancies between bioimpedance spectroscopy devices in haemodialysis patients
por: Dejongh, Sander, et al.
Publicado: (2019) -
Prevalence, progression and implications of breast artery calcification in patients with chronic kidney disease
por: Van Berkel, Brecht, et al.
Publicado: (2021) -
A pilot study comparing the efficiency of a novel asymmetric cellulose triacetate (ATA) dialyser membrane (Solacea‐190H) to a standard high flux polysulfone dialyser membrane (FX‐80) in the setting of extended hours haemodialysis
por: Kameshwar, Kamya, et al.
Publicado: (2022) -
Heparin-free regional anticoagulation of haemodialysis filters with calcium-free dialysate: is citrate mandatory?
por: Medrano, Chloé, et al.
Publicado: (2021) -
Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease
por: Poesen, Ruben, et al.
Publicado: (2014)